Company intelligence / Profile preview

Wuhan Sanwu Biotech

Wuhan, Hubei, China

Ownership: Private
Development stage: Other

Overview

Wuhan Sanwu Biotech is a high-tech enterprise based in Wuhan, China, specializing in the research, development, and manufacturing of in vitro diagnostic (IVD) reagents and instruments. The company focuses on rapid diagnostic solutions, including point-of-care testing (POCT) for infectious diseases, cardiovascular markers, and inflammatory indicators. Their product portfolio encompasses various detection platforms such as colloidal gold, fluorescence immunochromatography, and chemiluminescence. Wuhan Sanwu Biotech serves both domestic and international markets, providing diagnostic tools for clinical laboratories and healthcare providers.

Therapeutic areas: CardiovascularImmunologyInfectious Diseases
Modalities: In vitro diagnosticsAntibodyRecombinant protein
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Wuhan Sanwu Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wuhan Sanwu Biotech.

Explore the full profile